# UCM301 (NCT04620239)

> ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04620239
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Steba Biotech S.A.
- Conditions: Transitional Cell Cancer of Renal Pelvis and Ureter
- Interventions: padeliporfin VTP
- Enrollment: 89
- Primary outcome: Number of patients with absence of UTUC tumors in the entire ipsilateral calyces, renal pelvis and ureter

## Indexed commentary on UCM301 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 16
- YouTube: 5
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=ucm301-nct04620239

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04620239", "email": "<work email>"}; the inbox owner confirms by the emailed link.